A study of psychiatric comorbidities among treatment seeking opioid injectors attending tertiary care teaching hospital, Imphal for a period of 2 years

Mawiong, Andreecia Mn; Senjam, Gojendra; Haobam, Mary; Singh, Ningombam Heramani; Khongji, Phrangstone

doi:10.4103/jms.jms_61_17

Cited by 5 publications

(10 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 6 Similarly, a recent study in India on 105 people who inject opioids reported antisocial personality disorder in 85.7%, depression in 61.9%, polysubstance dependence in 52.4%, anxiety disorder in 41%, psychosis in 23.8%, suicide in 11.4%, panic disorder in 4.8%, and specific phobia in 4.8% of the individuals. 7 A study on 1769 young persons who inject drugs (PWID) (aged 18–29 years) from 20 US cities assessed probable serious mental illness (PSMI) using the Kessler-6 screening scale. Opioid users constituted more than two-thirds of the sample.…”

Section: Introductionmentioning

confidence: 99%

Psychiatric Comorbidity, Psychosocial Problems, and Functioning of People Who Inject Opioids: An Observational Study

et al. 2022

View full text Add to dashboard Cite

Background: Injecting drug use (IDU) is a growing concern in India. This problem may coexist with other psychiatric disorders. The psychiatric comorbidity in IDUrs affects the psychosocial functioning of this population. This study aimed to assess psychiatric comorbidities, psychosocial problems, and global functioning of people who inject opioids. Methods: This cross-sectional study included opioid-dependent individuals with a history of injecting opioids who visited an outpatient clinic for buprenorphine maintenance treatment. The patients were assessed by SCID-I and SCID-II for Axis–I and Axis–II psychiatric disorders, respectively. The diagnosis was confirmed according to DSM-IV-TR. Moreover, the assessment of psychosocial and environmental problems was done according to Axis-IV of DSM-IV. Functioning was assessed using the Global Assessment of Functioning Scale (GAF). Substance use severity was also assessed using Addiction Severity Index (ASI). Findings: A total of 100 participants were included in the study. All participants were male, and the majority (63%) were in the age range of 18-40 years with the mean age of 36.96 (SD=10.12). Moreover, 76% of the participants had psychiatric comorbidity. Mood disorder (28.95%), anxiety disorder (13.16%), any personality disorder (27.63%) were the most common comorbidities. The results also revealed psychosocial and environmental problems were significantly higher in participants with comorbidity and their global functioning was poor. Conclusion: Psychiatric comorbidities are quite common and are associated with various psychosocial and environmental problems. Early identification and interventions for comorbid conditions along with community-based psychosocial rehabilitation should be considered for better outcomes.

show abstract

Section: Introductionmentioning

confidence: 99%

Psychiatric Comorbidity, Psychosocial Problems, and Functioning of People Who Inject Opioids: An Observational Study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…About 62% of the study subjects in the non-OST group had a moderate level of stress (11.08 ± 0.58). A similar study conducted by Mawiong et al 15 on psychiatric comorbidities among treatment-seeking opioid injectors found that common psychiatric comorbidities were anti-social personality disorder (85.7%), followed by depression (61.9%), poly substance dependence (52.4%), anxiety disorder (41%), psychosis (23.8%), suicide (11.4%), panic disorder (4.8%) and specific phobia (4.8%).…”

Section: Discussionmentioning

confidence: 69%

“…According to the scores in the case of depression, these categories were as follows: no depression (0-9), mild (10)(11)(12)(13), moderate (14-20), severe (21-27) and extremely severe (28+). In the case of anxiety, these categories were as follows: no anxiety (0-7), mild (8)(9), moderate (10)(11)(12)(13)(14), severe (15)(16)(17)(18)(19) and extremely severe (20+). In the case of stress, these categories were as follows: no stress (0-14), mild (15)(16)(17)(18), moderate (19-25), severe (26-33) and extremely severe (34+).…”

Section: Methodsmentioning

confidence: 99%

“…In the case of anxiety, these categories were as follows: no anxiety (0-7), mild (8)(9), moderate (10)(11)(12)(13)(14), severe (15)(16)(17)(18)(19) and extremely severe (20+). In the case of stress, these categories were as follows: no stress (0-14), mild (15)(16)(17)(18), moderate (19-25), severe (26-33) and extremely severe (34+). 8 The depression scale assesses dysphoria, hopelessness, devaluation of life, self-deprecation, lack of interest/involvement, anhedonia and inertia.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

A Comparative Study to Assess the Mental Health Problems, Quality of Life, Work Ability and Social Adjustments Among OST and Non-OST Drug Users in Chandigarh

Kumar,

Sharma,

Saini

et al. 2022

Nursing & Midwifery Research Journal

View full text Add to dashboard Cite

Introduction: Injectable drug use is a cause of disease burden and a contributor to blood-borne virus transmission and health-related problems. It is one of the serious problems of our country. The best suitable strategy of treatment for opioid dependence is ‘opioid substitution therapy’ (OST). It is beneficial for the injectable drug users (IDUs) in reduction in the behaviour of injecting and opioid use, which helps in reducing criminal activities, domestic violence, enhancing ties within the family and improving productivity. Objective: To assess the mental health problems, quality of life, work ability and social adjustability among OST and non-OST IDUs. Materials and Methods: The descriptive study was conducted among 100 male IDUs (50 in the OST group and 50 in the non-OST group), registered with the two selected non-governmental organizations (NGOs) of Chandigarh selected by using the consecutive sampling technique. The OST group was contacted during their visit to the centre for receiving the daily dose of OST, while the non-OST group was contacted during their visit to the NGO centres for getting fresh syringes in exchange with used syringes under the syringe exchange programme. The data were collected by interviewing the study subjects by using the interview schedule comprising of the (a) socio-demographic profile, (b) health problems, (c) substance-use-related problems scale, (d) work ability and social adjustability scale, (e) the depression, anxiety and stress scale-21 and (f) World Health Organization Quality-of-Life BREF (WHOQOL BREF) Scale. All the tools were standardized and available in the open domain. Results: The study subjects were in the age group of 18–58 years with the mean age of 27.52 ± 6.67 years. Significantly lesser problems in the OST group study participants related to health, occupation, finance, legal, family, marital and social status were reported than those in the non-OST group participants ( t-test, p < 0.01). A significantly higher percentage of the study participants in the non-OST group had depression, anxiety and stress than that in the OST group. Quality of life of IDUs in the OST group was significantly better than that of IDUs in the non-OST group, as per the WHOQOL BREF Scale (Mann–Whitney U test, p < 0.05). Conclusion: IDUs on OST therapy (OST group) were having lesser problems in the area of health (physical and mental), occupational, financial, legal, family, marital, social and better quality of life than those in the non-OST group.

show abstract

“…One study reported the comorbidity of depression, anxiety, and suicidality among PWID (injecting opioids primarily) to be as high as 61.9%, 41%, and 11.4%, respectively. 22 Thus, such mental health helplines may be helpful to PWUO with psychiatric comorbidities. Such helplines can provide emergency aid without delay and, hence, may also be a blessing for the family members of such individuals who may be distressed.…”

mentioning

confidence: 99%

COVID-19 Pandemic and People Who Use Opioids in India: Opportunities and Evolutions

Parmar

Kumari

Padhy

2020

Indian Journal of Psychological Medicine

View full text Add to dashboard Cite

A study of psychiatric comorbidities among treatment seeking opioid injectors attending tertiary care teaching hospital, Imphal for a period of 2 years

Cited by 5 publications

References 0 publications

Psychiatric Comorbidity, Psychosocial Problems, and Functioning of People Who Inject Opioids: An Observational Study

Psychiatric Comorbidity, Psychosocial Problems, and Functioning of People Who Inject Opioids: An Observational Study

A Comparative Study to Assess the Mental Health Problems, Quality of Life, Work Ability and Social Adjustments Among OST and Non-OST Drug Users in Chandigarh

COVID-19 Pandemic and People Who Use Opioids in India: Opportunities and Evolutions

Contact Info

Product

Resources

About